THE IMPACT OF ADJUVANT THERAPY DELAY ON SURVIVAL FOLLOWING PANCREATICODUODENECTOMY FOR PANCREATIC ADENOCARCINOMA

被引：0
|
作者：
Kutlu, Onur
Lee, Jeffrey E.
de La Cruz, Nestor
Conrad, Claudius
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)34113-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1024
引用
收藏
页码：S1235 / S1235
页数：1
相关论文
共 50 条
  • [31] Is prior cholecystectomy associated with decreased survival in patients with resectable pancreatic adenocarcinoma following pancreaticoduodenectomy?
    Schiffman, Suzanne C.
    Chu, Carrie K.
    Park, Jaemin
    Russell, Maria
    Keilin, Steven
    Kooby, David A.
    Scoggins, Charles R.
    McMasters, Kelly M.
    Martin, Robert C. G.
    AMERICAN JOURNAL OF SURGERY, 2011, 201 (04): : 519 - 524
  • [32] The utilization and impact of adjuvant therapy following neoadjuvant therapy and resection of pancreatic adenocarcinoma: does more really matter?
    Drake, Justin A.
    Stiles, Zachary E.
    Behrman, Stephen W.
    Glazer, Evan S.
    Deneve, Jeremiah L.
    Somer, Bradley G.
    Vanderwalde, Noam A.
    Dickson, Paxton V.
    HPB, 2020, 22 (11) : 1530 - 1541
  • [33] Impact of timing of adjuvant chemotherapy initiation on survival in pancreatic adenocarcinoma.
    Palacio, Sofia
    Ripat, Caroline
    Stuart, Heather
    Yakoub, Danny
    Merchant, Nipun B.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [34] Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival - A prospective, single-institution experience
    Yeo, CJ
    Abrams, RA
    Grochow, LB
    Sohn, TA
    Ord, SE
    Hruban, RH
    Zahurak, ML
    Dooley, WC
    Coleman, J
    Sauter, PK
    Pitt, HA
    Lillemoe, KD
    Cameron, JL
    ANNALS OF SURGERY, 1997, 225 (05) : 621 - 633
  • [35] Comment on "The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma''
    Petrucciani, Niccolo
    Antolino, Laura
    Moschetta, Giovanni
    Ramacciato, Giovanni
    ANNALS OF SURGERY, 2019, 270 (06) : E129 - E130
  • [36] Chemoradiotherapy in adjuvant therapy of pancreatic adenocarcinoma
    Iannopollo, M.
    Ricasoli, M.
    Lencioni, M.
    Laliscia, C.
    Sainato, A.
    Orlandini, C.
    Del Chiaro, M.
    Boggi, U.
    Mosca, F.
    Cionini, L.
    Ricci, S.
    ANNALS OF ONCOLOGY, 2005, 16 : 49 - 49
  • [37] Association of textbook outcomes with improved survival in pancreatic ductal adenocarcinoma following pancreaticoduodenectomy: a retrospective study
    Wang, Haikuo
    Hu, Xiao
    Yin, Changjun
    Zhou, Dejiang
    Li, Zonglin
    Ma, Zifeng
    Zhang, Heyun
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 9
  • [38] The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma
    Nitta, Takeo
    Nakamura, Toru
    Mitsuhashi, Tomoko
    Asano, Toshimichi
    Okamura, Keisuke
    Tsuchikawa, Takahiro
    Tamoto, Eiji
    Murakami, Soichi
    Noji, Takehiro
    Kurashima, Yo
    Ebihara, Yuma
    Nakanishi, Yoshitsugu
    Shichinohe, Toshiaki
    Hirano, Satoshi
    SURGERY TODAY, 2017, 47 (04) : 490 - 497
  • [39] The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma
    Takeo Nitta
    Toru Nakamura
    Tomoko Mitsuhashi
    Toshimichi Asano
    Keisuke Okamura
    Takahiro Tsuchikawa
    Eiji Tamoto
    Soichi Murakami
    Takehiro Noji
    Yo Kurashima
    Yuma Ebihara
    Yoshitsugu Nakanishi
    Toshiaki Shichinohe
    Satoshi Hirano
    Surgery Today, 2017, 47 : 490 - 497
  • [40] Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: Impact of family history on outcome
    Herman, J. M.
    Pawlik, T. J.
    Swartz, M.
    Yu, H. M.
    Schulick, R.
    Winter, J.
    Laheru, D.
    Hruban, R.
    Klein, A. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345